Search dm+d | This VMP cannot be matched against our prescribing data.
| Name | Trivalent influenza vaccine (live attenuated) nasal suspension 0.2ml unit dose |
| BNF code | 1404000H0AAASAS |
| Virtual Therapeutic Moiety | Influenza vaccine |
| Abbreviated name | Trivalent influenza vacc (live attenuated) nsl susp 0.2ml ud |
| Basis of preferred name | Other |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Discrete |
| Unit dose form size | 0.200 |
| Unit dose form units | ml |
| Unit dose unit of measure | unit dose |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Influenza virus live attenuated |
| Ontology Drug Form & Route | |
| Form & Route | suspensionspray.nasal |
| Dose Form | |
| Formulation | Spray |
| Drug Route | |
| Route | Nasal |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| Fluenz (trivalent) vaccine nasal suspension 0.2ml unit dose (AstraZeneca UK Ltd) | |
| Virtual Medicinal Product Packs | |
| Trivalent influenza vaccine (live attenuated) nasal suspension 0.2ml unit dose 10 unit dose | |
dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.